MedTrace Logo

Capsaicin in Treatment of Rhinogenic Headache

NCT03330639 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2024-09-03

No results posted yet for this study

Summary

Description: Capsaicin (8- methyl-N-vanillyl-6-nonenamide) has been demonstrated to have a therapeutic effect in idiopathic rhinitis. We hypothesize that capsaicin has a therapeutic effect on rhinogenic headaches, in addition to the previously studied decongestive effects. This study aims to evaluate capsaicin impact on headaches attributed to V1, V2 distribution of the sinonasal cavity. This study is a randomized, double-blinded, parallel trial.

Conditions

  • Headache Disorders

Interventions

OTHER

Capsaicin

Capsaicin is a homeopathic medication and there for this drug is not subject to the requirements of the FDA.

OTHER

Placebo

This group will receive the saline placebo solution.

Sponsors & Collaborators

  • University of Nebraska

    lead OTHER

Principal Investigators

  • Christie Barnes, MD · University of Nebraska

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-23
Primary Completion
2020-06-23
Completion
2020-06-23

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03330639 on ClinicalTrials.gov